跳至主要内容
临床试验/CTRI/2019/08/020822
CTRI/2019/08/020822尚未招募未知

Severity, Antibody responses and Immuneprotection after Scrub typhus

Christian Medical College0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Fever more than or equal to 38°C for 3 - 14 days. With a confirmed diagnosis of scrub typhus by IgM ELISA / RDT / Eschar and PCR

排除标准

  • HIV infection or other immunosuppressive conditions and co infections

研究者

相似试验

已完成
4 期
Safety, tolerability, and antibody response after intradermal vaccination of COVID-19 vaccine; PFE-BNT in adults who have completed two-doses of Verocell (inactivated vaccine)ocal reactions and systemic reactions after ID injection of PFE-BNT , antibody response after ID injection of PFE-BNTimmunogenicityside effects
TCTR20211023002ampang Hospital42
招募中
4 期
Immunologic response to hepatitis B immunization in children post liver transplantatioSafety and efficacy of hepatitis B vaccine, standard compare to double dose in short and long term follow-up.infection, bleeding, pain
TCTR20180723002Chulalonkorn University72
尚未招募
2 期
Immunogenic response of different antigenic values: investigation of intradermal purified Vero cell rabies vaccine in healthy volunteersImmunogenic response of different antigenic valuesintradermal purified Vero cell rabies vaccineimmunogenic responsedifferent antigenic valuesrabies vaccinehealthy volunteerintradermalpurified Vero cell rabies vaccine
TCTR20190314002BIOGENETECH CO.,LTD200
已完成
不适用
Assessment of the humoral immune response and safety of reduced doses of influenza vaccine administered intradermally compared to intramuscular administratioInfections and InfestationsInfluenza
ISRCTN33950739Berna Biotech AG, Crucell Company (Switzerland)275
招募中
2 期
Preliminary study: Safety and Immunological Response following COVID-19 Vaccination in COVID-19 survivorsCOVID-19 survivorsCOVID-19 Vaccination
TCTR20210720005Faculty of Medicine Siriraj Hospital180